Home Your basket
• The use of ultrasound eva...
   Price 8.50 €
• A case of laryngeal sialo...
   Price 10.50 €
• Cataract surgery and its ...
   Price 10.50 €
• Failure to regain full fu...
   Price 10.50 €
• The ultra-low resistance ...
   Price 5.50 €
• Choanal atresia: therapeu...
   Price 10.50 €
• A new case of osseointegr...
   Price 12.50 €
• Airbag and hearing loss: ...
   Price 8.50 €
• Drop weld thermal injurie...
   Price 8.50 €
• Vibration induced nystagm...
   Price 10.50 €
• Type III ossiculoplasty w...
   Price 5.50 €
• Facial aesthetic lipostru...
   Price 10.50 €
• Thyroid pseudo-nodules: 3...
   Price 5.50 €
• Role and importance of pH...
   Price 12.00 €
• Transverse maxillary defi...
   Price 8.50 €
• The cost of running a mul...
   Price 5.50 €
• The application of tusso...
   Price 10.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• The lymphoepithelial carc...
   Price 5.50 €
• Quality of life after oro...
   Price 10.50 €
• F0 characteristics in Par...
   Price 12.00 €
• The value of the operatin...
   Price 10.50 €
• Mucoepidermoid carcinomas...
   Price 10.50 €
• Otoplasty for prominent e...
   Price 8.50 €
• Inferior turbinate hypert...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Silent Sinus Syndrome – T...
   Price 8.50 €
• XVIth World Congress of O...
   Price 8.50 €
• Extraction of the esophag...
   Price 8.50 €
• Rhinoplasty: Morphodynami...
   Price 10.50 €
• Cutaneous horn of the pin...
   Price 5.50 €
• The sound intensity after...
   Price 10.50 €
• Sentinel lymph node biops...
   Price 10.50 €
• Videonystagmography and v...
   Price 10.50 €
• Bone anchored hearing aid...
   Price 8.50 €
• Validation of a self-asse...
   Price 10.50 €
• Laryngeal paraganglioma m...
   Price 8.50 €
• Anterior cerebrospinal fl...
   Price 10.00 €

Total Order 343.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2005 o

HEAD AND NECK

Metastatic angiosarcoma to the thyroid


Authors : S. P. Eng, C. H. K. Goh, J. B. K. Khoo, T. L. Yang, L. H. Y. Lim (Singapore)

Ref. : Rev Laryngol Otol Rhinol. 2005;126,2:111-114.

Article published in english
Downloadable PDF document english



Summary : Background: Angiosarcoma (AS) in non-alpine areas is exceptionally rare, and so is metastatic AS to the thyroid. The difficulties and controversies associated with its diagnosis and management are highlighted in this case report. Method: Case report. Results: A Chinese gentleman with AS metastatic to the thyroid presented a year after radiotherapy to his scalp AS. There was rapid expansion of the metastasis over 2 weeks and invasion of the pyriform fossa caused dysphagia and haemoptysis. The diagnosis was established by paraffin histology of the tumour post-hemithyroidectomy, after repeated fine-needle aspiration cytology was not diagnostic. Patient opted for external beam radiotherapy to the pyriform fossa instead of pharyngolaryngectomy. Residual pyriform tumour was treated with brachytherapy delivered via nasogastric tube. Unfortunately, the patient died 4 months later due to cardiac failure which was unrelated to his oncologic condition. Conclusion: AS metastatic to the thyroid is possible. The unexpectedly acute presentation and difficulties associated with diagnosis and management are highlighted. A useful method of delivering brachytherapy to the pyriform fossa is described.

Price : 5.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE